At EMKAM Pharma, we are committed to conducting our business with the utmost integrity and ethical standards. We have a zero-tolerance approach towards bribery, corruption, and any form of unethical behavior. Our Anti-Bribery Anti-Corruption (ABAC) policy outlines our firm stance and serves as a guiding framework for all employees, partners, and stakeholders.

Preventing Bribery and Corruption

We firmly believe that maintaining trust and transparency in all our business dealings is paramount. We prohibit any form of bribery or corruption, whether it involves public officials, private entities, or individuals. We ensure that our employees and business partners understand and comply with anti-bribery laws and regulations applicable in the countries where we operate.

Compliance with Laws and Regulations

EMKAM Pharma operates in full compliance with the laws and regulations related to anti-bribery and anti-corruption, including the U.S. Foreign Corrupt Practices Act (FCPA), the UK Bribery Act, and other relevant legislation. We are committed to upholding the highest standards of legal and ethical conduct across all aspects of our operations.

Policies and Procedures

We have established robust policies and procedures to prevent bribery and corruption within our organization. These include clear guidelines on gift and hospitality practices, facilitation payments, conflicts of interest, and due diligence processes for engaging with third parties. Our policies are regularly reviewed and updated to align with evolving best practices and regulatory requirements.

Risk Assessment and Due Diligence

We conduct comprehensive risk assessments to identify and evaluate potential bribery and corruption risks associated with our business activities. Through due diligence procedures, we carefully assess the integrity and reputation of our business partners, suppliers, contractors, and agents. We engage in transactions only with those who uphold the same high ethical standards as we do.

Training and Awareness

We recognize the importance of continuous training and awareness in fostering a culture of integrity and compliance. We provide regular anti-bribery and anti-corruption training to our employees, ensuring they understand their responsibilities and the potential risks associated with bribery and corruption. We encourage all employees to report any concerns or suspicions promptly through our confidential reporting channels.

Monitoring and Enforcement

EMKAM Pharma maintains robust monitoring and enforcement mechanisms to ensure adherence to our ABAC policy. We conduct internal audits, reviews, and investigations to identify and address any potential breaches. We take prompt action when instances of bribery or corruption are discovered, including disciplinary measures and, if necessary, reporting to relevant authorities.

Continuous Improvement

We are committed to continuously improving our ABAC efforts and strengthening our safeguards against bribery and corruption. We regularly review our policies, procedures, and controls, taking into account emerging risks and best practices. We actively engage with industry initiatives, professional organizations, and regulatory bodies to stay updated on the latest developments in anti-bribery and anti-corruption measures.

Reporting Violations

EMKAM Pharma encourages a culture of reporting any suspected breaches of our ABAC policy. We provide multiple reporting channels, ensuring confidentiality and protection for whistleblowers. We are committed to thoroughly investigating all reports and taking appropriate action, treating all individuals involved with fairness and impartiality.

As a responsible corporate citizen, EMKAM Pharma is dedicated to upholding the highest standards of ethics, integrity, and accountability. We strive to be a trusted partner for our stakeholders, fostering a business environment free from bribery and corruption. Together, we can build a sustainable future based on transparency, trust, and ethical conduct.